Therapeutic Developed using Novel Approach to Drug Discovery has Successfully Completed Phase 1 Clinical Trial
OTTAWA, Canada, Oct. 15, 2020 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering GPCR-targeted therapeutics, today announced the